5 research outputs found
A Dataset of Anatomical Environments for Medical Robots: Modeling Respiratory Deformation
Anatomical models of a medical robot's environment can significantly help
guide design and development of a new robotic system. These models can be used
for benchmarking motion planning algorithms, evaluating controllers, optimizing
mechanical design choices, simulating procedures, and even as resources for
data generation. Currently, the time-consuming task of generating these
environments is repeatedly performed by individual research groups and rarely
shared broadly. This not only leads to redundant efforts, but also makes it
challenging to compare systems and algorithms accurately. In this work, we
present a collection of clinically-relevant anatomical environments for medical
robots operating in the lungs. Since anatomical deformation is a fundamental
challenge for medical robots operating in the lungs, we describe a way to model
respiratory deformation in these environments using patient-derived data. We
share the environments and deformation data publicly by adding them to the
Medical Robotics Anatomical Dataset (Med-RAD), our public dataset of anatomical
environments for medical robots
Autonomous Medical Needle Steering In Vivo
The use of needles to access sites within organs is fundamental to many
interventional medical procedures both for diagnosis and treatment. Safe and
accurate navigation of a needle through living tissue to an intra-tissue target
is currently often challenging or infeasible due to the presence of anatomical
obstacles in the tissue, high levels of uncertainty, and natural tissue motion
(e.g., due to breathing). Medical robots capable of automating needle-based
procedures in vivo have the potential to overcome these challenges and enable
an enhanced level of patient care and safety. In this paper, we show the first
medical robot that autonomously navigates a needle inside living tissue around
anatomical obstacles to an intra-tissue target. Our system leverages an aiming
device and a laser-patterned highly flexible steerable needle, a type of needle
capable of maneuvering along curvilinear trajectories to avoid obstacles. The
autonomous robot accounts for anatomical obstacles and uncertainty in living
tissue/needle interaction with replanning and control and accounts for
respiratory motion by defining safe insertion time windows during the breathing
cycle. We apply the system to lung biopsy, which is critical in the diagnosis
of lung cancer, the leading cause of cancer-related death in the United States.
We demonstrate successful performance of our system in multiple in vivo porcine
studies and also demonstrate that our approach leveraging autonomous needle
steering outperforms a standard manual clinical technique for lung nodule
access.Comment: 22 pages, 6 figure
High Expression of HIF1a Is a Predictor of Clinical Outcome in Patients with Pancreatic Ductal Adenocarcinomas and Correlated to PDGFA, VEGF, and bFGF
PURPOSE: Pancreatic cancer still has one of the worst prognoses in gastrointestinal cancers with a 5-year survival rate of 5%, making it necessary to find markers or gene sets that would further classify patients into different risk categories and thus allow more individually adapted multimodality treatment regimens. In this study, we investigated the prognostic values of HIF1a, bFGF, VEGF, and PDGFA gene expressions as well as their interrelationships. EXPERIMENTAL DESIGN: Formalin-fixed paraffin-embedded tissue samples were obtained from 41 patients with pancreatic adenocarcinoma (age, 65; range, 34–85 years). After laser capture microdissection, direct quantitative real-time reverse transcription-polymerase chain reaction assays were performed in triplicates to determine HIF1a, PDGFA, VEGF, and bFGF gene expression levels. Multivariate Cox proportional hazards regression analysis was used to assess the impact of HIF1a gene expression on prognosis. RESULTS:HIF1a was significantly correlated to every gene we tested: bFGF (P = .04), VEGF (P = .02), and PDGFA (P = .03). Tumor size, P = .04, and high HIF1a mRNA expression (cutoff, 75th percentile) had a significant impact on survival, P = .009 (overall model fit, P = .02). High HIF1a expression had a sensitivity of 87.1% and a specificity of 55.6% for the diagnosis short (<6 months) versus long (6–60 months) survival. CONCLUSIONS: Measuring PDGFA, bFGF, and HIF1a expression may contribute to a better understanding of the prognosis of patients with pancreatic cancer and may even play a crucial role for the distribution of patients to multimodal therapeutic regimens. Larger studies including patients treated with actual chemotherapeutics seem to be warranted